Skip to main content

TableĀ 1 Demographic and clinical feature at the time of presentation of children with bacteremia from ESBL group and non ESBL group E. coli or Klebsiella spp.

From: Clinical epidemiology, risk factors and treatment outcomes of extended-spectrum beta-lactamase producing Enterobacteriaceae bacteremia among children in a Tertiary Care Hospital, Bangkok, Thailand

Ā 

Non-ESBL (n=45)

ESBL (n=52)

P-value

Sex (M:F)

26:19

27:25

0.334

Meanā€‰Ā±ā€‰SD of age (month)

65ā€‰Ā±ā€‰81

69ā€‰Ā±ā€‰75

0.708

Meanā€‰Ā±ā€‰SD of length of stay

37ā€‰Ā±ā€‰57

93ā€‰Ā±ā€‰180

0.083

Day

25

40

<ā€‰0.01

Underlying disease

Ā Hematological malignancy

8

15

0.463

Ā Solid tumor

2

2

0.661

Ā Nephrotic syndrome

2

3

1

Ā Congenital heart disease

1

12

<ā€‰0.01

Ā End stage renal disease

3

3

0.661

Ā SLE

0

2

0.497

Ā Preterm

7

0

<ā€‰0.01

Ā Newborn

2

1

0.595

Ā Chronic lung disease

0

2

0.497

Ā Neurological problem

4

4

0.729

Focal infection

Ā Pneumonia

10

21

0.17

Ā Urinary tract infection

13

14

0.58

Ā Diarrhea

1

5

0.18

Ā Cellulitis

1

3

0.54

Ā Ascending cholangitis

2

0

0.15

Ā Meningitis

2

2

0.72

Mortality (%)

6 (13.3%)

20 (38.9%)

<ā€‰0.05

  1. ESBL group: patient with bacteremia caused by ESBL producingā€”E. coli or Klebsiella spp.
  2. Non-ESBL group: patient with bacteremia caused by non-ESBL producingā€”E. coli or Klebsiella spp.